This inventor holds 1 USPTO granted patent. Top assignee: Dracen Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Gary Elliott: Innovator in Pharmaceutical Composition
Introduction
Gary Elliott is a notable inventor based in Windsor, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for intravenous administration.
Latest Patents
Elliott holds a patent for a lyophilized composition comprising (S)-isopropyl 2-((S)-2-acetamido-3-(1H-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate. This patent focuses on the formulation and use of lyophilates that include this specific compound, which has potential applications in pharmaceutical compositions and formulations.
Career Highlights
Throughout his career, Gary Elliott has been associated with Dracen Pharmaceuticals, Inc., where he has played a crucial role in advancing pharmaceutical innovations. His work has contributed to the development of new therapeutic options for patients.
Collaborations
Elliott has collaborated with esteemed colleagues such as Steven Dykstra and Thomas M Estok, further enhancing the impact of his work in the pharmaceutical industry.
Conclusion
Gary Elliott's contributions to pharmaceutical innovations, particularly through his patented compositions, highlight his role as a key inventor in the field. His work continues to influence the development of effective medical treatments.